Jens D. Lundgren

Use of observational databases to evaluate the effectiveness of antiretroviral therapy for HIV infection: comparison of cohort studies with randomized trials. EuroSIDA, the French Hospital Database on HIV and the Swiss HIV Cohort Study Groups.

M. Egger, A. Phillips, J. Lundgren, 1999, AIDS.

Short‐term weight gain after antiretroviral therapy initiation and subsequent risk of cardiovascular disease and diabetes: the D:A:D study

A. Mocroft, A. d’Arminio Monforte, J. Lundgren, 2016, HIV medicine.

Interruption of Antiretroviral Therapy and Risk of Cardiovascular Disease in Persons with HIV-1 Infection: Exploratory Analyses from the SMART Trial

A. Hatzakis, B. Grund, J. Neuhaus, 2008, Antiviral therapy.

State of the Science Conference: Initiative to Decrease Cardiovascular Risk and Increase Quality of Care for Patients Living With HIV/AIDS Executive Summary

K. Yarasheski, S. Lipshultz, P. Hsue, 2008, Circulation.

Survival in 2367 zidovudine-treated patients according to use of other nucleoside analogue drugs. The EuroSIDA Study Group.

A. Blaxhult, B. Clotet, C. Katlama, 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Potential cost-effectiveness of community availability of tenofovir, lamivudine, and dolutegravir for HIV prevention and treatment in east, central, southern, and west Africa: a modelling analysis.

P. Revill, C. Gilks, P. Ehrenkranz, 2023, The Lancet. Global health.